ChemRar Ventures
Invests in early stages of innovative pharmaceutical drugs development (from pre-clinic stage and up to phase II of clinic stage including).
ChemRar is a pioneering pharmaceutical company focused on developing and producing effective, safe, and affordable drugs to treat socially significant diseases. Operating primarily in the Russian market, ChemRar serves a wide range of clients including healthcare providers, research institutions, and pharmaceutical companies. The company’s business model revolves around research and development (R&D), contractual production, and commercialization of innovative pharmaceuticals and diagnostics. ChemRar generates revenue through the sale of pharmaceutical products, R&D services, and contractual manufacturing agreements. By leveraging its extensive experience and adhering to global standards, ChemRar aims to improve the quality of life for patients worldwide, particularly in Russia, by addressing diseases that have effective treatments. The company also contributes to the scientific and technological capacity of the Russian pharmaceutical industry.
Keywords: innovative pharmaceuticals, diagnostics, life-threatening diseases, R&D, contractual production, commercialization, healthcare, Russian market, affordable drugs, scientific capacity.